Activity of Pemetrexed (ALIMTA®, Multitargeted Antifolate, LY231514) in Metastatic Breast Cancer Patients Previously Treated with an Anthracycline and a Taxane: An Interim Analysis
- 1 April 2001
- journal article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 2 (1) , 47-51
- https://doi.org/10.3816/cbc.2001.n.010
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Phase III Comparative Study of Vinorelbine Combined With Doxorubicin Versus Doxorubicin Alone in Disseminated Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8Journal of Clinical Oncology, 2000
- Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast CancerJournal of Clinical Oncology, 1999
- Treatment of Breast CancerNew England Journal of Medicine, 1998
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group.Journal of Clinical Oncology, 1996
- Continuous 5-fluorouracil in the treatment of breast cancerBritish Journal of Cancer, 1994
- Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteriaInvestigational New Drugs, 1992
- Ten-Year Results of FAC Adjuvant Chemotherapy Trial in Breast CancerAmerican Journal of Clinical Oncology, 1989